| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 68.6% | 35/51 |
| Female | 31.4% | 16/51 |
| Indifferent | 0% | 0/51 |
| Unknown | 0% | 0/51 |
| General | ||
| 13.5% | 5/37 | |
| 21.6% | 8/37 | |
| 16.2% | 6/37 | |
| 13.7% | 7/51 | |
| 37.3% | 19/51 | |
| 28.6% | 14/49 | |
| 74.5% | 35/47 | |
| 95.9% | 47/49 | |
| 94.1% | 48/51 | |
| 89.6% | 43/48 | |
| Neurology | ||
| 92.2% | 47/51 | |
| 78.4% | 40/51 | |
| 29.4% | 15/51 | |
| Facial abnormalities | ||
| 41.2% | 21/51 | |
| 78.4% | 40/51 | |
| 41.2% | 21/51 | |
| 64.7% | 33/51 | |
| Visual and hearing impairments | ||
| 5.9% | 3/51 | |
| 45.1% | 23/51 | |
| Heart | ||
| 7.8% | 4/51 | |
| Pulmonary | ||
| Abnormality of the lungs | 0% | 0/4 |
| Gastrointestinal | ||
| 43.1% | 22/51 | |
| Urogenital | ||
| 13.7% | 7/51 | |
| Skeleton | ||
| 64.7% | 33/51 | |
| Skin / Hair / Nails | ||
| 47.1% | 24/51 | |
| Endocrine / Immunological / Metabolic | ||
| 2% | 1/51 | |
| Metabolic | 0% | 0/51 |
| 21.6% | 11/51 | |
| Neoplasia | ||
| Neoplasia | 0% | 0/51 |
| Inheritance | ||
| 100% | 47/47 | |
FBXO11